68th Indian Pharmaceutical Congress (IPC) is organised and started at city of happening, Visakhapatnam under the premises of Andhra University. More than 9000 delegates and students from various part of India participated in this event. This event is organised in Andhra University for three days, 16th to 18th December 2016. The main theme of the event is Quality pharmaceuticals & patients welfare.
CDSCO decided to abolish practice of pre-inspection by State Licensing Authority & Central Licensing Authority for issuing Form 29 License to manufacture drugs for purposes of examination, test or analysis for biological products (Vaccines & r-DNA products).
[adsense:336x280:8701650588]
Government of India has taken a series of steps as part of its 'Digital India' initiative. In pursuance of this, the Ministry of Health and Family Welfare has also been making efforts to leverage Information and Communication Technology for improving efficiency and effectiveness of the healthcare delivery in the country.
Hon’ble Bombay high court rejects petition of Sun Pharmaceuticals Industries Ltd. filed against price fixing of Ciprofloxacin HCL Tablet 250 mg by National Pharmaceutical Pricing Authority (NPPA). Sun Pharma filed petition under paragraph 31 of the Drugs (Prices Control) Order, 2013 against notification S.O. No.1882(E) dated 13.07.2015 issued by the NPPA fixing the ceiling price of Ciprofloxacin.
The Indian Pharmaceutical Association (IPA) strongly opposes the ideas which arise through some recent news indicates that there have been discussion regarding enabling the unqualified persons to be "pharmacists" by initiating some training courses. IPA firmly stated that medical stores/pharmacies should be run only in presence and under supervision of qualified, registered pharmacists.
In 74th meeting of Drugs Technical Advisory Board (DTAB), committee agreed for the proposal that the manufacturing and sale licences once issued, shall remain valid forever, unless suspended or cancelled by the Licensing Authority.
The Association of Indian Medical Device Industry (AiMeD) has applauded Govt’s move that comes in the wake of Finance Ministry urging RBI to undertake an audit of all investments made in medical device sector over policy loopholes and confusion over definitional distinction between medical device and pharma sector leading to increased vulnerability of Indian pharma companies and no real gains for domestic medical device manufacturing.
The US regulatory department is all set to launch criminal report against 14 generic pharmaceuticals for conspiring to set medicine prices.
India may have emerged as a key supplier of generic and affordable medicine for the world market, its overwhelming dependence on China for a crucial raw material , known as Active Pharmaceutical Ingredient (API)to the extent of over 65 percent of the requirement, has emerged as a main worrying area.
DCGI (Drugs Controller General of India) extends validity of approval of Bioavailability and Bioequivalence Centre from one year to three years to facilitate ease of working.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
